Nonsteroidal anti‐inflammatory drugs (NSAID) and aspirin for preventing recurrence and metachronous colorectal carcinomas in patients previously treated for colorectal cancer

非甾体抗炎药（NSAID）和阿司匹林用于预防既往接受过结直肠癌治疗的患者发生结直肠癌复发和异时性结直肠癌。

阅读：1
作者：Cahill,Kate,Perera,Rafael,Mumtaz,Khalid,Ahmed,Umair Syed,Zuberi,Nadeem F,Salamat,Sumaira,Jafri,Wasim,Shah,Prakeshkumar S,Njei,Basile,Garg,Sushil K,Sethi,Saurabh,Kongnyuy,Eugene J,Upadhyay,Amit,Chawla,Deepak,Joshi,Payas,Davis,Peter G,Sun,Ying-Shi,Li,Xiao-Ting,Tang,Lei,Zhang,Xiao-Yan,Cui,Yong,Zhang,Xiao-Peng,Zehra,Faryal,Siddiqui,Muhammed Rafay Sameem,Andrews,Karen G,Faiz,Omar,Jalaludin,Bin,Warusavitarne,Janindra,Robinson,Stuart,Moir,John AG,Pedley,Ian,Manas,Derek M,White,Steven A,Zuo,Long,Yue,Xin,Bian,Tao,Cai,Yiqun,Wang,Licheng,Zeng,Linmiao,He,Hongmei,Wang,Linning,Ioannou,Adam,Li,Shaoke,Nielsen,Emil Eik,Feinberg,Joshua,Wetterslev,Jørn,Gluud,Christian,Jakobsen,Janus C,Latchford,Andrew R,Maeda,Yasuko,Clark,Susan K
期刊：Cochrane Database of Systematic Reviews影响因子：9.400
时间：2020起止号：2020;2020(3):CD004986
doi：10.1002/14651858.CD004986.pub4研究方向： 肿瘤
疾病类型： 肠癌

Abstract

This protocol for a Cochrane Review has been withdrawn.
 
 Reason for withdrawal: Authors have made no progress with this protocol in 3 years. New authors are being sought to take over this protocol.
 
 The protocol is being withdrawn by Kristoffer Andresen, Managing Editor ‐ Cochrane Colorectal Group. The authors have agreed to the withdrawal.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用；引用内容仅为补充信息，不代表本站立场。

2、若认为本页面引用内容涉及侵权，请及时与本站联系，我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容，需注明“来源：[生知库]”并获得授权；使用引用内容的，需自行联系原作者获得许可。

4、投稿及合作请联系：info@biocloudy.com。